Pitt D, Connelly J, Francis I, Wilcken B, Brown D A, Robertson E, Hill G, Masters P, Raby J, McFarlane J, Bowling F, Hancock J
Med J Aust. 1983 Apr 2;1(7):333-5. doi: 10.5694/j.1326-5377.1983.tb136112.x.
Since screening of newborn infants for phenylketonuria (PKU) by the Guthrie bacterial inhibition assay was established in the 1960s, 3 017 703 infants have been tested in Australia. Two hundred and fifty-one cases of PKU (0.83/10 000) and six cases of the variant forms of malignant hyperphenylalaninaemia (MHPA) (0.02/10 000) have been detected. In 1981, 11 infants with PKU were detected. Screening for congenital hypothyroidism was carried out in seven States, and 66 new cases were detected in 1981 (2.13/10 000). In Adelaide, 154 310 infants have been tested for galactosaemia and a total of seven cases have now been detected (0.45/10 000). In New South Wales, 35 955 infants have been tested for cystic fibrosis of the pancreas, and 17 cases were found (4.73/10 000).
自20世纪60年代通过格思里细菌抑制试验对新生儿进行苯丙酮尿症(PKU)筛查以来,澳大利亚已有3017703名婴儿接受了检测。已检测出251例苯丙酮尿症(0.83/10000)和6例恶性高苯丙氨酸血症(MHPA)变异型(0.02/10000)。1981年,检测出11例苯丙酮尿症患儿。在七个州开展了先天性甲状腺功能减退症筛查,1981年检测出66例新病例(2.13/10000)。在阿德莱德,154310名婴儿接受了半乳糖血症检测,目前共检测出7例(0.45/10000)。在新南威尔士州,35955名婴儿接受了胰腺囊性纤维化检测,发现17例(4.73/10000)。